Silymarin Ameliorates Metabolic Dysfunction Associated with Diet-Induced Obesity via Activation of Farnesyl X Receptor.
about
Morin, a novel liver X receptor α/β dual antagonist, has potent therapeutic efficacy for nonalcoholic fatty liver diseases.Silibinin Reduces the Impact of Obesity on Invasive Liver Cancer.Update on FXR Biology: Promising Therapeutic Target?Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD
P2860
Silymarin Ameliorates Metabolic Dysfunction Associated with Diet-Induced Obesity via Activation of Farnesyl X Receptor.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Silymarin Ameliorates Metaboli ...... vation of Farnesyl X Receptor.
@en
Silymarin Ameliorates Metaboli ...... vation of Farnesyl X Receptor.
@nl
type
label
Silymarin Ameliorates Metaboli ...... vation of Farnesyl X Receptor.
@en
Silymarin Ameliorates Metaboli ...... vation of Farnesyl X Receptor.
@nl
prefLabel
Silymarin Ameliorates Metaboli ...... vation of Farnesyl X Receptor.
@en
Silymarin Ameliorates Metaboli ...... vation of Farnesyl X Receptor.
@nl
P2093
P2860
P356
P1476
Silymarin Ameliorates Metaboli ...... ivation of Farnesyl X Receptor
@en
P2093
Cheng Huang
Jinwen Huang
Shengjie Fan
Yahui Wang
Yuanyuan Zhao
P2860
P356
10.3389/FPHAR.2016.00345
P577
2016-09-28T00:00:00Z